These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 20819548)
1. Effects of 5-hydroxytryptamine and 5-hydroxytryptamine 2A/2C agonist on the genioglossus activity and sleep apnea in rats. Zhong YJ; Zhang C; Wang GF Chin Med J (Engl); 2010 Aug; 123(15):2094-8. PubMed ID: 20819548 [TBL] [Abstract][Full Text] [Related]
2. [Effects of 5-HT2 agonist/antagonist on sleep apnea in Sprague-Dawley rats]. Zhong YJ; Zhang C; Wang GF Zhonghua Jie He He Hu Xi Za Zhi; 2010 May; 33(5):350-3. PubMed ID: 20646613 [TBL] [Abstract][Full Text] [Related]
4. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Carley DW; Radulovacki M Am J Respir Crit Care Med; 1999 Dec; 160(6):1824-9. PubMed ID: 10588592 [TBL] [Abstract][Full Text] [Related]
5. Systemic administration of serotonin 2A/2C agonist improves upper airway stability in Zucker rats. Ogasa T; Ray AD; Michlin CP; Farkas GA; Grant BJ; Magalang UJ Am J Respir Crit Care Med; 2004 Oct; 170(7):804-10. PubMed ID: 15256396 [TBL] [Abstract][Full Text] [Related]
6. Serotonin at the laterodorsal tegmental nucleus suppresses rapid-eye-movement sleep in freely behaving rats. Horner RL; Sanford LD; Annis D; Pack AI; Morrison AR J Neurosci; 1997 Oct; 17(19):7541-52. PubMed ID: 9295399 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of central Na(+)/H(+) exchanger type 3 can alleviate sleep apnea in Sprague-Dawley rats. Wang Q; Zhou R; Zhang C; Dong H; Ma J; Wang G Chin Med J (Engl); 2014; 127(1):48-53. PubMed ID: 24384423 [TBL] [Abstract][Full Text] [Related]
8. Serotonin control of sleep-wake behavior. Monti JM Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634 [TBL] [Abstract][Full Text] [Related]
9. Functional role for cannabinoids in respiratory stability during sleep. Carley DW; Paviovic S; Janelidze M; Radulovacki M Sleep; 2002 Jun; 25(4):391-8. PubMed ID: 12071539 [TBL] [Abstract][Full Text] [Related]
11. A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat. Amici R; Sanford LD; Kearney K; McInerney B; Ross RJ; Horner RL; Morrison AR Brain Res; 2004 Jan; 996(1):9-18. PubMed ID: 14670626 [TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats. Calik MW; Carley DW J Negat Results Biomed; 2016 May; 15():8. PubMed ID: 27133202 [TBL] [Abstract][Full Text] [Related]
14. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus. Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228 [TBL] [Abstract][Full Text] [Related]
15. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury. Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520 [TBL] [Abstract][Full Text] [Related]
16. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats. Carley DW; Depoortere H; Radulovacki M Pharmacol Biochem Behav; 2001; 69(1-2):283-9. PubMed ID: 11420096 [TBL] [Abstract][Full Text] [Related]
17. Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apneas in rats. Radulovacki M; Trbovic SM; Carley DW Sleep; 1998 Mar; 21(2):131-6. PubMed ID: 9542796 [TBL] [Abstract][Full Text] [Related]
18. Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states. Chan E; Steenland HW; Liu H; Horner RL Am J Respir Crit Care Med; 2006 Dec; 174(11):1264-73. PubMed ID: 16931636 [TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. Ross JD; Herin DV; Frankel PS; Thomas ML; Cunningham KA Drug Alcohol Depend; 2006 Feb; 81(2):117-27. PubMed ID: 16054778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]